Term
Which receptor do the neruomuscular blocking agents work at? |
|
Definition
|
|
Term
What are the two general classes of neuromuscular blocking agents? |
|
Definition
Nondepolarizing competative blockers
Depolarizing blockers |
|
|
Term
What are the drugs that fall into the two classes of blocking agents? |
|
Definition
non-depolarizing: d-TC (d-tubocurarine)
depolarizing: succinylcholine |
|
|
Term
Which of the classes is short lived? |
|
Definition
|
|
Term
Why is succinylcholine short lived? |
|
Definition
because it is metabolized by plasma cholinesterase |
|
|
Term
Where is d-TC metabolized? |
|
Definition
|
|
Term
What does d-TC cause the muscle to do? |
|
Definition
|
|
Term
What does succinylcholine initial cause the muscle to do? |
|
Definition
|
|
Term
Which muscles are effected first by the neuromuscular blocking agents? |
|
Definition
the highly innervated muscles (eyes, fingers) first then the limbs, diaphram, intercostal muscles |
|
|
Term
Which muscles come back to normal first after stopping the neuromuscular blocking agent? |
|
Definition
|
|
Term
How are the neuromuscular agents administered and how long until they act? |
|
Definition
administered IV and take effect within 1-3 minutes |
|
|
Term
How long does d-TC and Succinylcholine last? |
|
Definition
d-TC about 30 mins
Sux less than 5 mins |
|
|
Term
What are the uses for d-TC? (4) |
|
Definition
ET intubation
Electric shock therapy
vent
with anesthia |
|
|
Term
What are the uses for Sux? (2) |
|
Definition
intubation
short procedures |
|
|
Term
What are the adverse effects of d-TC? (2) |
|
Definition
prolonged weakness
histamine release |
|
|
Term
What does the induced histamine release by d-TC cause? (3) |
|
Definition
hypotension
increased bronchial secretion
bronchoconstriction |
|
|
Term
What are the adverse effects of Sux? (4) |
|
Definition
people with genetic polymorphism w/o full plasma cholinesterase activity will have longer apnea
watch for patients with malignant hypothermia
intense skeletal muscle contractions
hyperkalemia |
|
|
Term
What type of patients is SUX contraindicated in? (2) |
|
Definition
those with malignant hypothermia
skeletal muscle problems |
|
|
Term
Why can Sux lead to hyperkalemia?
What will the hyperkalemia lead to? |
|
Definition
because of intense muscle contractions, potassium leaks out of cell
leads to heart arrhythmia |
|
|
Term
What is the treatment for malignent hyperthermia induced by Sux? (3) |
|
Definition
stop the Sux
ice the patient
give Na-Dantrolene |
|
|
Term
What are the signs of malignant hyperthermia? (2) |
|
Definition
muscle rigidity
increased temperature as much as 43 degrees |
|
|
Term
How is malignant hyperthermia determined? |
|
Definition
|
|
Term
What other condition studied in this module is associated with malignant hyperthermia? |
|
Definition
central core disease (a congenital myopathy) |
|
|
Term
What drug interaction with the d-TC will cause a decrease in the d-TC effect? |
|
Definition
|
|
Term
How can d-TC be reversed? |
|
Definition
|
|
Term
Why when Sux is administered with an anti-achE does the effect of Sux go up? |
|
Definition
the anti-achE effects both plasma cholinesterase and the achE in the neuro junction
the Sux is broken down by the plasma cholinesterase
therefore wiht less cholinesterase the Sux will not be inactivated and there will be more around |
|
|